Opus Genetics (IRD) Operating Income (2010 - 2026)
Opus Genetics (IRD) reported Operating Income of -$14.4 million for Q1 2026, down 44.67% year-over-year from -$26.0 million in Q1 2025, and down 25.42% on a QoQ basis from -$11.5 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Operating Income data on file, last reported at -$14.4 million in Q1 2026.
- Quarterly Operating Income fell 44.67% year-over-year to -$14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.0 million (up 33.07% YoY) and the FY2025 annual result came in at -$38.6 million, up 37.82% from the prior year.
- Operating Income fell to -$14.4 million in Q1 2026 per IRD's latest filing, from -$11.5 million in the prior quarter.
- Across five years, Operating Income topped out at $34.2 million in Q4 2022 and bottomed at -$38.0 million in Q4 2024.
- The 5-year median for Operating Income is -$7.7 million (2024), against an average of -$6.3 million.
- The widest annual swing landed in 2022, when Operating Income jumped 656.26%; it then tumbled 600.48% in 2024.
- Tracing IRD's Operating Income over 5 years: stood at $34.2 million in 2022, then slumped by 115.87% to -$5.4 million in 2023, then plunged by 600.48% to -$38.0 million in 2024, then jumped by 69.88% to -$11.5 million in 2025, then dropped by 25.42% to -$14.4 million in 2026.
- Per Business Quant, the three latest IRD Operating Income figures stand at -$14.4 million (Q1 2026), -$11.5 million (Q4 2025), and -$8.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -14.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.36 Mn |
| Dec 31, 2025 | -11.45 Mn |
| Sep 30, 2025 | -8.31 Mn |
| Jun 30, 2025 | -8.91 Mn |
| Mar 31, 2025 | -9.93 Mn |
| Dec 31, 2024 | -38.03 Mn |
| Sep 30, 2024 | -8.01 Mn |
| Jun 30, 2024 | -8.33 Mn |
| Mar 31, 2024 | -7.71 Mn |
| Dec 31, 2023 | -5.43 Mn |
| Sep 30, 2023 | 6.39 Mn |
| Jun 30, 2023 | -5.39 Mn |
| Mar 31, 2023 | -6.13 Mn |
| Dec 31, 2022 | 34.21 Mn |
| Sep 30, 2022 | -4.54 Mn |
| Jun 30, 2022 | -4.94 Mn |
| Mar 31, 2022 | -6.51 Mn |
| Dec 31, 2021 | -6.15 Mn |
| Sep 30, 2021 | -4.23 Mn |
| Jun 30, 2021 | -7.14 Mn |
| Mar 31, 2021 | -5.19 Mn |
| Dec 31, 2020 | -14.02 Mn |
| Sep 30, 2020 | -1.95 Mn |
| Jun 30, 2020 | -1.26 Mn |
| Mar 31, 2020 | -2.74 Mn |
| Dec 31, 2019 | 5.01 Mn |
| Sep 30, 2019 | -2.28 Mn |
| Jun 30, 2019 | -2.99 Mn |
| Mar 31, 2019 | -3.94 Mn |
| Dec 31, 2018 | -4.97 Mn |
| Sep 30, 2018 | -4.68 Mn |
| Jun 30, 2018 | -5.00 Mn |
| Mar 31, 2018 | -5.89 Mn |
| Dec 31, 2017 | -4.90 Mn |
| Sep 30, 2017 | -4.22 Mn |
| Jun 30, 2017 | -4.28 Mn |
| Mar 31, 2017 | -3.95 Mn |
| Dec 31, 2016 | -3.92 Mn |
| Sep 30, 2016 | -3.72 Mn |
| Jun 30, 2016 | -3.91 Mn |
| Mar 31, 2016 | -4.86 Mn |
| Dec 31, 2015 | -4.37 Mn |
| Sep 30, 2015 | -4.66 Mn |
| Jun 30, 2015 | -4.82 Mn |
| Mar 31, 2015 | -4.42 Mn |
| Dec 31, 2014 | -3.85 Mn |
| Sep 30, 2014 | -3.14 Mn |
| Jun 30, 2014 | -3.51 Mn |
| Mar 31, 2014 | -2.77 Mn |
| Dec 31, 2013 | -2.33 Mn |
| Sep 30, 2013 | -1.82 Mn |
| Jun 30, 2013 | -1.91 Mn |
| Mar 31, 2013 | -1.91 Mn |
| Dec 31, 2012 | -1.05 Mn |
| Sep 30, 2012 | -1.80 Mn |
| Jun 30, 2012 | -1.85 Mn |
| Mar 31, 2012 | -1.88 Mn |
| Dec 31, 2011 | -2.40 Mn |
| Sep 30, 2011 | -3.36 Mn |
| Jun 30, 2011 | -6.46 Mn |
| Mar 31, 2011 | -3.91 Mn |
| Dec 31, 2010 | -3.16 Mn |
| Sep 30, 2010 | -2.37 Mn |
| Jun 30, 2010 | -3.19 Mn |